Your browser doesn't support javascript.
loading
Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patients.
Yang, Bingyu; Wang, Chang; Xie, Yiyu; Xu, Liangjing; Wu, Xiaojin; Wu, Depei.
Afiliación
  • Yang B; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Wang C; Institute of Blood and Marrow Transplantation, Suzhou, China.
  • Xie Y; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Xu L; Key Laboratory of Stem Cells and Biomedical Materials of Jiangsu Province and Chinese Ministry of Science and Technology, Suzhou, China.
  • Wu X; State Key Laboratory of Radiation Medicine and Protection, Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Soochow University, Suzho
  • Wu D; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Cancer Sci ; 109(3): 777-784, 2018 Mar.
Article en En | MEDLINE | ID: mdl-29316075

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas / Metaboloma / Metabolómica Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Cancer Sci Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas / Metaboloma / Metabolómica Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Cancer Sci Año: 2018 Tipo del documento: Article País de afiliación: China